Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
FBRX Forte Biosciences
- 9.380
- -0.270-2.80%
Close Feb 25 16:00 ET
- 9.380
- 0.0000.00%
Post 16:05 ET
59.97MMarket Cap-0.57P/E (TTM)
10.080High8.800Low14.52KVolume9.540Open9.650Pre Close137.04KTurnover0.43%Turnover RatioLossP/E (Static)6.39MShares28.68052wk High6.40P/B31.76MFloat Cap4.11052wk Low--Dividend TTM3.39MShs Float6732.375Historical High--Div YieldTTM13.26%Amplitude4.110Historical Low9.437Avg Price1Lot Size
About Forte Biosciences Company
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Company Profile
SymbolFBRX
Company NameForte Biosciences
Listing DateApr 13, 2017
Issue Price10.00
Founded2017
CEODr. Paul A. Wagner, PhD
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address3060 Pegasus Park Drive,Building 6
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75247
Phone1-310-618-6994
Websitehttp://www.fortebiorx.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul A. Wagner, PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.45M
- Antony A. Riley
- Chief Financial Officer
- 722.98K
- Dr. Barbara K. Finck, M.D.
- Director
- 61.73K
- Donald A. Williams
- Independent Director
- 85.73K
- Dr. Scott C. Brun, M.D.
- Independent Director
- 62.73K
- Dr. Stephen K. Doberstein, PhD
- Independent Director
- 62.73K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 62.73K
- Steven Kornfeld
- Independent Director
- 97.73K
- David W. Gryska, M.B.A.
- Independent Director
- 104.30K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.